Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Calculating correct Down's syndrome risks.

H Cuckle1, I Sehmi

  • 1Centre for Reproduction, Growth and Development, University of Leeds, UK.

British Journal of Obstetrics and Gynaecology
|July 30, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Change in prevalence of preterm birth in Israel following publication of national guidelines recommending routine sonographic cervical-length measurement at 19-25 weeks' gestation.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2022
Same author

Quality assessment of first-trimester screening for preterm pre-eclampsia.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2022
Same author

Re: Routine first-trimester combined screening for pre-eclampsia: pregnancy-associated plasma protein-A or placental growth factor?

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2022
Same author

Early pregnancy prediction of spontaneous preterm birth before 32 completed weeks of pregnancy using plasma RNA: transcriptome discovery and initial validation of an RNA panel of markers.

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

United States' experience in nuchal translucency measurement: variation according to provider characteristics in over five million ultrasound examinations.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2021
Same author

Rethinking second-trimester Down-syndrome screening in the cell-free DNA era.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2019
Same journal

Livial: an economic appraisal.

British journal of obstetrics and gynaecology·2000
Same journal

Livial: a review of clinical studies.

British journal of obstetrics and gynaecology·2000
Same journal

Place of birth and shoulder dystocia.

British journal of obstetrics and gynaecology·1999
Same journal

The value of the negative predictive values.

British journal of obstetrics and gynaecology·1999
Same journal

Splenectomy during pregnancy: an option in treatment of autoimmune thrombocytopenic purpura.

British journal of obstetrics and gynaecology·1999
Same journal

Third trimester abortion: is compassion enough?

British journal of obstetrics and gynaecology·1999
See all related articles

Calculating a combined risk for Down syndrome is essential when using both nuchal translucency and serum screening tests. This method provides accurate Down syndrome risk assessment for pregnant women.

Area of Science:

  • Maternal-Fetal Medicine
  • Prenatal Diagnostics
  • Genetics

Background:

  • First-trimester nuchal translucency (NT) and second-trimester serum screening are common prenatal tests.
  • These tests often yield disparate Down syndrome risk assessments.
  • Individually reported risks may not accurately reflect the combined predictive value.

Purpose of the Study:

  • To present a method for calculating a valid combined risk for Down syndrome.
  • To integrate results from nuchal translucency and serum screening tests.
  • To improve the accuracy of prenatal Down syndrome risk assessment.

Main Methods:

  • Utilizing the reported serum-based Down syndrome risk.
  • Deriving a likelihood ratio from the nuchal translucency (NT) report.

Related Experiment Videos

  • Employing provided tables, figures, and examples for calculation.

    • Main Results:

    • A method to calculate a single, accurate combined Down syndrome risk is described.
    • The approach integrates NT measurements (in multiples of the normal median or in millimeters with crown-rump length) and prior risk estimates.
    • This ensures a more precise risk assessment than using individual test results.

    Conclusions:

    • Combined risk calculation offers a more accurate Down syndrome risk assessment.
    • This method enhances the clinical utility of combined first and second-trimester screening.
    • Accurate risk assessment is crucial for informed decision-making in prenatal care.